167 related articles for article (PubMed ID: 36630995)
21. A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis.
Gindin Y; Chung C; Jiang Z; Zhou JZ; Xu J; Billin AN; Myers RP; Goodman Z; Landi A; Houghton M; Green RM; Levy C; Kowdley KV; Bowlus CL; Muir AJ; Trauner M
Hepatology; 2021 Mar; 73(3):1105-1116. PubMed ID: 32745270
[TBL] [Abstract][Full Text] [Related]
22. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis.
Overi D; Carpino G; Franchitto A; Onori P; Gaudio E
Cells; 2020 Mar; 9(3):. PubMed ID: 32131439
[TBL] [Abstract][Full Text] [Related]
24. Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
Van Campenhout S; Tilleman L; Lefere S; Vandierendonck A; Raevens S; Verhelst X; Geerts A; Van Nieuwerburgh F; Van Vlierberghe H; Devisscher L
Metabolism; 2020 Jun; 107():154220. PubMed ID: 32243868
[TBL] [Abstract][Full Text] [Related]
25. The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.
Kazankov K; Barrera F; Møller HJ; Rosso C; Bugianesi E; David E; Younes R; Esmaili S; Eslam M; McLeod D; Bibby BM; Vilstrup H; George J; Grønbaek H
Liver Int; 2016 Oct; 36(10):1549-57. PubMed ID: 27102725
[TBL] [Abstract][Full Text] [Related]
26. Integrin β
Guo Q; Furuta K; Lucien F; Gutierrez Sanchez LH; Hirsova P; Krishnan A; Kabashima A; Pavelko KD; Madden B; Alhuwaish H; Gao Y; Revzin A; Ibrahim SH
J Hepatol; 2019 Dec; 71(6):1193-1205. PubMed ID: 31433301
[TBL] [Abstract][Full Text] [Related]
27. Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis.
Broomé U; Grunewald J; Scheynius A; Olerup O; Hultcrantz R
J Hepatol; 1997 Mar; 26(3):527-34. PubMed ID: 9075659
[TBL] [Abstract][Full Text] [Related]
28. Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis.
De Muynck K; Heyerick L; De Ponti FF; Vanderborght B; Meese T; Van Campenhout S; Baudonck L; Gijbels E; Rodrigues PM; Banales JM; Vesterhuus M; Folseraas T; Scott CL; Vinken M; Van der Linden M; Hoorens A; Van Dorpe J; Lefere S; Geerts A; Van Nieuwerburgh F; Verhelst X; Van Vlierberghe H; Devisscher L
Hepatology; 2024 Feb; 79(2):269-288. PubMed ID: 37535809
[TBL] [Abstract][Full Text] [Related]
29. Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis.
Qing J; Ren Y; Zhang Y; Yan M; Zhang H; Wu D; Ma Y; Chen Y; Huang X; Wu Q; Mazhar M; Wang L; Liu J; Ding BS; Cao Z
J Hepatol; 2022 Feb; 76(2):394-406. PubMed ID: 34648896
[TBL] [Abstract][Full Text] [Related]
30. Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis.
Broomé U; Scheynius A; Hultcrantz R
Hepatology; 1993 Aug; 18(2):298-303. PubMed ID: 8340058
[TBL] [Abstract][Full Text] [Related]
31. Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver.
Andrews TS; Nakib D; Perciani CT; Ma XZ; Liu L; Winter E; Camat D; Chung SW; Lumanto P; Manuel J; Mangroo S; Hansen B; Arpinder B; Thoeni C; Sayed B; Feld J; Gehring A; Gulamhusein A; Hirschfield GM; Ricciuto A; Bader GD; McGilvray ID; MacParland S
J Hepatol; 2024 May; 80(5):730-743. PubMed ID: 38199298
[TBL] [Abstract][Full Text] [Related]
32. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
[TBL] [Abstract][Full Text] [Related]
33. PNPLA3 I148M polymorphism and progressive liver disease.
Dongiovanni P; Donati B; Fares R; Lombardi R; Mancina RM; Romeo S; Valenti L
World J Gastroenterol; 2013 Nov; 19(41):6969-78. PubMed ID: 24222941
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of ductular reaction in non-alcoholic steatohepatitis.
Chen Y; Gao WK; Shu YY; Ye J
World J Gastroenterol; 2022 May; 28(19):2088-2099. PubMed ID: 35664038
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation profile of liver tissue in end-stage cholestatic liver disease.
Cheung AC; Juran BD; Schlicht EM; McCauley BM; Atkinson EJ; Moore R; Heimbach JK; Watt KD; Wu TT; LaRusso NF; Gores GJ; Sun Z; Lazaridis KN
Epigenomics; 2022 Apr; 14(8):481-497. PubMed ID: 35473391
[TBL] [Abstract][Full Text] [Related]
36. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
Chen Y; Guldiken N; Spurny M; Mohammed HH; Haybaeck J; Pollheimer MJ; Fickert P; Gassler N; Jeon MK; Trautwein C; Strnad P
J Pathol; 2015 Nov; 237(3):343-54. PubMed ID: 26108453
[TBL] [Abstract][Full Text] [Related]
37. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
[TBL] [Abstract][Full Text] [Related]
38. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
[TBL] [Abstract][Full Text] [Related]
39. Histological and immunohistochemical study of the gall bladder lesion in primary sclerosing cholangitis.
Jeffrey GP; Reed WD; Carrello S; Shilkin KB
Gut; 1991 Apr; 32(4):424-9. PubMed ID: 2026342
[TBL] [Abstract][Full Text] [Related]
40. Profiling of mouse and human liver diseases identifies targets for therapeutic treatment of autoimmune hepatitis.
Centa M; Thermidor C; Fiel MI; Alexandropoulos K
Clin Immunol; 2023 Nov; 256():109807. PubMed ID: 37821072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
